Mage-D1 inhibits proliferation, migration and invasion of human breast cancer cells

Oncology Reports

Volumn 22, Issue 3, 2009, Pages 659-665

  Du, Qiang ^a   Zhang, Yang ^a   Tian, Xin Xia ^a   Li, Yan ^a   Fang, Wei Gang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Breast cancer; Invasion; MAGE D1

Indexed keywords

BETA CATENIN; PROTEIN MAGE D1; PROTEIN P21; PROTEIN P53; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN; MAGED1 PROTEIN, HUMAN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL COUNT; CELL CYCLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING; BREAST TUMOR; CANCER INVASION; CELL MOTION; FEMALE; GENETICS; PATHOLOGY; PHYSIOLOGY;

ANTIGENS, NEOPLASM; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PLASMIDS; TRANSFECTION;

EID: 70349309807     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000486     Document Type: Article

References (31)

1. Tavtigian SV, Simard J, Rommens J, et al: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12: 333-337, 1996.
2. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 Science 265: 2088-2090, 1994.
3. Gayther SA, Pharoah PD and Ponder BA: The genetics of inherited breast cancer. J Mammary Gland Biol Neoplasia 3: 365-376, 1998.
4. Tian XX, Rai D, Li J, et al: BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Cancer Res 65: 4747-4753, 2005.
5. Barker PA and Salehi A: The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 67: 705-712, 2002.
6. Salehi A, Hinck L and Watanabe K: RumMAGE-D the members: structure and function of a new adaptor family of MAGE-D proteins. J Recept Signal Transduct Res 25: 181-198, 2005.
7. Tsai JR, Chong IW, Chen YH, et al: Differential expression profile of MAGE family in non-small-cell lung cancer. Lung Cancer 56: 185-192, 2007.
8. Kirkin AF, Dzhandzhugazyan KN and Zeuthen J: Cancer/testis antigens: structural and immunobiological properties. Cancer Invest 20: 222-236, 2002.
9. Stone B, Schummer M, Paley PJ, et al: MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily. Gene 267: 173-182, 2001.
10. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61: 5544-5551, 2001.
11. Xue B, Wen C, Shi Y, Zhao D and Li C: Human NRAGE disrupts E-cadherin/ beta-catenin regulated homotypic cell-cell adhesion. Biochem Biophys Res Commun 336: 247-251, 2005.
12. Shen WG, Yue QY, Zhu J, et al: Inhibition of adenovirus-mediated human MAGE-D1 on angiogenesis in vitro and in vivo. Mol Cell Biochem 300: 89-99, 2007.
13. Masuda Y, Sasaki A, Shibuya H, Ueno N, Ikeda K and Watanabe K: Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function. J Biol Chem 276: 5331-5338, 2001.
14. Kuwajima T, Taniura H, Nishimura I and Yoshikawa K: Necdin interacts with the Msx2 homeodomain protein via MAGE-D1 to promote myogenic differentiation of C2C12 cells. J Biol Chem 279: 40484-40493, 2004.
15. Salehi AH, Roux PP, Kubu CJ, et al: NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 27: 279-288, 2000.
16. Williams ME, Strickland P, Watanabe K and Hinck L: UNC5H1 induces apoptosis via its juxtamembrane region through an interaction with NRAGE. J Biol Chem 278: 17483-17490, 2003.
17. Matsuda T, Suzuki H, Oishi I, et al: The receptor tyrosine kinase Ror2 associates with the melanoma associated antigen (MAGE) family protein Dlxin-1 and regulates its intracellular distribution. J Biol Chem 278: 29057-29064, 2003.
18. Jordan BW, Dinev D, Le Mellay V, et al: Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death. J Biol Chem 276: 39985-39989, 2001.
19. Sasaki A, Masuda Y, Iwai K, Ikeda K and Watanabe K: A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein Dlxin-1. J Biol Chem 277: 22541-22546, 2002.
20. Di Certo MG, Corbi N, Bruno T, et al: NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death. J Cell Sci 120: 1852-1858, 2007.
21. Chu CS, Xue B, Tu C, et al: NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo. Cancer Lett 250: 268-275, 2007.
22. Zhang YG, Du Q, Fang WG, Jin ML and Tian XX: Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells. Int J Oncol 33: 595-602, 2008.
23. Takaoka K, Kishimoto H, Segawa E, et al: Elevated cell migration, invasion and tumorigenicity in human KB carcinoma cells transfected with COX-2 cDNA. Int J Oncol 29: 1095-1101, 2006.
24. Tian XX, Lam PY, Chen J, et al: Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation. Neuropathol Appl Neurobiol 24: 389-396, 1998.
25. Wen CG, Xue B, Qin WX, et al: hNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation. FEBS Lett 564: 171-176, 2004.
26. Kendall SE, Battelli C, Irwin S, et al: NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade. Mol Cell Biol 25: 7711-7724, 2005.
27. Salehi AH, Xanthoudakis S and Barker PA: NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J Biol Chem 277: 48043-48050, 2002.
28. Cowin P, Rowlands TM and Hatsell SJ: Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17: 499-508, 2005.
29. Decock J, Paridaens R and Cufer T: Proteases and metastasis: clinical relevance nowadays? Curr Opin Oncol 17: 545-550, 2005.
30. Zhang YG, DU J, Tian XX, Zhong YF and Fang WG: Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas. Chin Med J (Engl) 120: 1597-1605, 2007.
31. Chabottaux V and Noel A: Breast cancer progression: insights into multifaceted matrix metalloproteinases. Clin Exp Metastasis 24: 647-656, 2007.